> Products > CAS NO 110-91-8

China CAS NO 110-91-8 Factory

The buyer pleasure is our primary concentrate on. We uphold a consistent level of professionalism, excellent, credibility and service for CAS NO 110-91-8,110-91-8,Apixaban intermediate,Apixaban advance intermediate,Morpholine, Trust us and you will gain more. Please feel free to contact us for more information, we assure you of our best attention at all times.
CAS NO 110-91-8, Our company has abundant strength and possesses a steady and perfect sales network system. We wish we could establish sound business relationships with all customers from at home and abroad on the basis of mutual benefits.

Hot Products

Allyl chloroformate
Product Name:Allyl chloroformate
Molecular Formula:C4H5ClO2
Molecular Weight:120.53
CAS Registry Number;2937-50-0
2,6-Dibromopyridine
Product Name:2,6-Dibromopyridine
Molecular Formula:C5H3Br2N
Molecular Weight:236.89
CAS Registry Number:626-05-1
Azithromycin dihydrate
Product Name:Azithromycin dihydrate
Molecular Formula:C38H74N2O13
Molecular Weight;767.01
CAS Registry Number;117772-70-0
Pimecrolimus
Product Name:Pimecrolimus
Molecular Formula:C43H68ClNO11
Molecular Weight;810.45
CAS Registry Number;137071-32-0
Glycidyl methacrylate
Product Name:Glycidyl methacrylate
Molecular Formula:C7H10O3
Molecular Weight:142.15
CAS Registry Number:106-91-2
6-Chloro-2-benzoxazolethiol
Product Name:6-Chloro-2-benzoxazolethiol
Molecular Formula:C7H4ClNOS
Molecular Weight:185.63
CAS Registry Number:22876-20-6

Related Blog
Reviews

What Is Misoprostol Used For?
Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...
CAS No. 144689-24-7 Olmesartan Introduction
Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...
Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.
Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry
Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...
How much do you know about minocycline hydrochloride?
Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

China CAS NO 110-91-8 Factory

Related Products

Hot Products

Allyl chloroformate

2,6-Dibromopyridine

Azithromycin dihydrate

Pimecrolimus

Glycidyl methacrylate

6-Chloro-2-benzoxazolethiol

What Is Misoprostol Used For?

CAS No. 144689-24-7 Olmesartan Introduction

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

How much do you know about minocycline hydrochloride?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Camille 2023-09-10 09:19:53

Flora 2024-04-21 09:40:29

Grace 2024-05-12 16:25:21

Meredith 2023-04-17 10:55:38

Ivan 2023-01-12 05:53:10

Alexander 2022-04-30 14:10:02

Send Inquiry